Barclays’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-24,846
| Closed | -$263K | – | 4537 |
|
|
2022
Q4 | $263K | Buy |
+24,846
| New | +$263K | ﹤0.01% | 2957 |
|
|
2021
Q4 | – | Sell |
-77,683
| Closed | -$497K | – | 3952 |
|
|
2021
Q3 | $497K | Buy |
77,683
+70,667
| +1,007% | +$452K | ﹤0.01% | 2615 |
|
|
2021
Q2 | $59K | Buy |
7,016
+6,698
| +2,106% | +$56.3K | ﹤0.01% | 3332 |
|
|
2021
Q1 | $3K | Buy |
318
+123
| +63% | +$1.16K | ﹤0.01% | 3811 |
|
|
2020
Q4 | $3K | Sell |
195
-22,549
| -99% | -$347K | ﹤0.01% | 3483 |
|
|
2020
Q3 | $292K | Buy |
+22,744
| New | +$292K | ﹤0.01% | 2560 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | – | – | 4015 |
|
|
2019
Q4 | $0 | Sell |
1
-3,769
| -100% | – | ﹤0.01% | 4353 |
|
|
2019
Q3 | $26K | Sell |
3,770
-4,048
| -52% | -$27.9K | ﹤0.01% | 3816 |
|
|
2019
Q2 | $95K | Buy |
+7,818
| New | +$95K | ﹤0.01% | 3617 |
|